Use of propofol anesthesia and adjunctive treatment with levetiracetam and gabapentin in managing status epilepticus in a patient of acute intermittent porphyria.
Bhatia
Rohit
R
Vibha
Deepti
D
Srivastava
M V Padma
MV
Prasad
Kameshwar
K
Tripathi
Manjari
M
Bhushan Singh
Mamta
M
D000588:Amines / Q000627:therapeutic use*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage*; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D015897:Comorbidity; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D000077206:Gabapentin; D006801:Humans; D000077287:Levetiracetam; D008297:Male; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017118:Porphyria, Acute Intermittent / Q000188:drug therapy* / Q000453:epidemiology; D015742:Propofol / Q000008:administration & dosage*; D013226:Status Epilepticus / Q000188:drug therapy* / Q000453:epidemiology; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D018686:Anesthetics, Intravenous; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D000077287:Levetiracetam; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D015742:Propofol; D010889:Piracetam